Ligand validation:2IBK

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2IBK_EDO_A_408	20%	81%	0.202	0.805	0.5	0.32	-	-	0	0	100%	1
2IBK_EDO_E_406	19%	82%	0.208	0.799	0.65	0.15	-	-	0	0	100%	1
2IBK_EDO_A_407	0%	78%	0.737	0.733	0.55	0.33	-	-	0	0	100%	1
3FDS_EDO_A_356	56%	71%	0.103	0.875	0.46	0.62	-	-	0	0	100%	1
2IA6_EDO_F_602	42%	71%	0.169	0.888	1.02	0.11	-	-	0	0	100%	1
1JXL_EDO_T_1204	4%	22%	0.377	0.761	3.04	0.42	2	-	1	0	100%	1
1RYS_EDO_F_1204	2%	31%	0.392	0.65	2.36	0.53	2	-	2	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1
1EB6_EDO_A_1180	100%	64%	0.041	0.986	0.62	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.